TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.26
-0.27 (-4.80%)
At close: Jan 20, 2026, 4:00 PM EST
5.26
0.00 (0.00%)
After-hours: Jan 20, 2026, 5:25 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Innovative Drug Delivery Technology and Immune-oncology Therapeutics
18.51M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
18.51M